StockWatch
·
Pharmaceuticals
Quarterly Result28 Oct 2026, 09:11 pm

Aarti Pharmalabs Board Approves Q2 FY27 Unaudited Results, Appoints New CFO

AI Summary

Aarti Pharmalabs Ltd announced that its Board of Directors, in a meeting held on October 28, 2026, approved the unaudited financial results for the quarter and half-year ended September 30, 2026. The company also disclosed the resignation of Piyush Lakhani as Chief Financial Officer (CFO) and Key Managerial Personnel, effective October 30, 2026, to pursue other career opportunities. Subsequently, Smt. Vibha Thakkar has been appointed as the new CFO and Key Managerial Personnel, effective October 31, 2026. Smt. Thakkar brings over 18 years of experience in finance across various industries. The financial results and limited review report have been uploaded to the company's website.

Key Highlights

  • Board approved unaudited financial results for Q2 and H1 FY27.
  • Piyush Lakhani resigned as CFO and KMP.
  • Smt. Vibha Thakkar appointed as new CFO and KMP.
  • Vibha Thakkar has over 18 years of finance experience.
  • Financial results are available on the company website.